.jpg "Analysts")
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aimmune Therapeutics (NASDAQ: AIMT), VBI Vaccines (NASDAQ: VBIV) and Voyager Therapeutics Inc (NASDAQ: VYGR) with bullish sentiments.
Aimmune Therapeutics (NASDAQ: AIMT)
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Aimmune Therapeutics (NASDAQ: AIMT), with a price target of $72. The company’s shares opened today at $28.92.
According to TipRanks.com, Moussatos is a 4-star analyst with an average return of 9.5% and a 43.4% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as Allena Pharmaceuticals Inc, Global Blood Therapeutics, and Catabasis Pharmaceuticals.
Currently, the analyst consensus on Aimmune Therapeutics is Strong Buy and the average price target is $59.57, representing a 106.0% upside.
In a report released yesterday, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $64 price target.
See today’s analyst top recommended stocks >>
VBI Vaccines (NASDAQ: VBIV)
In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on VBI Vaccines (NASDAQ: VBIV), with a price target of $10. The company’s shares opened today at $3, close to its 52-week low of $2.82.
According to TipRanks.com, Newman is a 5-star analyst with an average return of 16.1% and a 45.3% success rate. Newman covers the Healthcare sector, focusing on stocks such as Hutchison China MediTech Ltd, Synergy Pharmaceuticals Inc, and Aileron Therapeutics Inc.
VBI Vaccines has an analyst consensus of Moderate Buy, with a price target consensus of $10.
Voyager Therapeutics Inc (NASDAQ: VYGR)
In a report released today, Phil Nadeau from Cowen & Co. maintained a Buy rating on Voyager Therapeutics Inc (NASDAQ: VYGR). The company’s shares opened today at $18.92.
According to TipRanks.com, Nadeau is a 5-star analyst with an average return of 12.4% and a 51.6% success rate. Nadeau covers the Healthcare sector, focusing on stocks such as Rocket Pharmaceuticals Inc, Adverum Biotechnologies, and Vertex Pharmaceuticals.
Voyager Therapeutics Inc has an analyst consensus of Strong Buy, with a price target consensus of $36.14.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
